Tyvaso and Intestinal haemorrhage - a phase IV clinical study of FDA data

Summary:

Intestinal haemorrhage is reported as a side effect among people who take Tyvaso (treprostinil sodium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Adcirca, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Intestinal haemorrhage when taking Tyvaso. It is created by eHealthMe based on reports of 37,923 people who have side effects when taking Tyvaso from the FDA, and is updated regularly.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.

What is Intestinal haemorrhage?

Intestinal haemorrhage (bleeding from intestine) is found to be associated with 538 drugs and 667 conditions by eHealthMe. Check the latest studies of Intestinal haemorrhage.

On Aug, 04, 2026

37,923 people reported to have side effects when taking Tyvaso.
Among them, 17 people (0.04%) have Intestinal haemorrhage.

Could Tyvaso cause Intestinal haemorrhage?

Among these 17 people:

How long have people been on Tyvaso when they have Intestinal haemorrhage? *

What is the gender of people who have Intestinal haemorrhage when taking Tyvaso? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Intestinal haemorrhage when taking Tyvaso? *

What are other drugs people take besides Tyvaso? *

What are other side effects people have besides Intestinal haemorrhage? *

Haemoglobin Decreased: 5 people, 29.41%
Joint Pain: 5 people, 29.41%
Hereditary Haemorrhagic Telangiectasia (hereditary -development of multiple abnormalities in the blood vessels): 3 people, 17.65%
Melaena (the passage of black, tarry stools): 3 people, 17.65%
Anaemia (lack of blood): 2 people, 11.76%
Rectal Haemorrhage (bleeding from anus): 2 people, 11.76%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.76%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 2 people, 11.76%
Neoplasm Malignant (cancer tumour): 2 people, 11.76%
Fainting (loss of consciousness and postural tone): 1 person, 5.88%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 64.71%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 29.41%
Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Tyvaso and have Intestinal haemorrhage?

- Check whether Intestinal haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tyvaso:

Tyvaso (37,941 reports)

Browse all side effects of Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal haemorrhage:

Intestinal haemorrhage (538 drugs)

Browse all the conditions that are associated with Intestinal haemorrhage:

Intestinal haemorrhage (667 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil sodium (the active ingredients of Tyvaso) and Tyvaso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.